−0.26 CAD
−13.19 M CAD
0.00 CAD
44.48 M
About DEFENCE THERAPEUTICS INC
Sector
CEO
Sébastien Plouffe
Headquarters
Vancouver
Website
Founded
2017
FIGI
BBG010VMGPV8
Defence Therapeutics, Inc. engages in the research and development of anti-body drug conjugates. It focuses on enhancing intracellular delivery of biological or biosimilar therapeutic drugs targeting cancer and infectious diseases. The company was founded by Simon Beaudoin and Sébastien Plouffe on July 18, 2017 and is headquartered in Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DTC is 0.52 CAD — it has decreased by −5.45% in the past 24 hours. Watch DEFENCE THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange DEFENCE THERAPEUTICS INC stocks are traded under the ticker DTC.
DTC stock has fallen by −13.33% compared to the previous week, the month change is a −17.46% fall, over the last year DEFENCE THERAPEUTICS INC has showed a −81.36% decrease.
DTC stock is 5.77% volatile and has beta coefficient of 1.33. Track DEFENCE THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is DEFENCE THERAPEUTICS INC there?
Today DEFENCE THERAPEUTICS INC has the market capitalization of 24.49 M, it has decreased by −8.33% over the last week.
Yes, you can track DEFENCE THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
DTC net income for the last quarter is −606.86 K CAD, while the quarter before that showed −1.35 M CAD of net income which accounts for 54.99% change. Track more DEFENCE THERAPEUTICS INC financial stats to get the full picture.
No, DTC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DTC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DEFENCE THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DEFENCE THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DEFENCE THERAPEUTICS INC stock shows the sell signal. See more of DEFENCE THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.